SMALL-CAP WINNERS & LOSERS: Roquefort jumps on Oncogeni deal

(Alliance News) - The following stocks are the leading risers and fallers among London Main ...

Alliance News 10 March, 2025 | 10:04AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

----------

SMALL-CAP - WINNERS

----------

Roquefort Therapeutics PLC, up 54% at 2.38 pence, 12-month range 1.40p-8.30p. The biotechnology firm signs a term sheet for the proposed sale of Oncogeni Ltd to Nations Trust Holding LLC for USD12 million. "The proposed sale of Oncogeni is an important step towards completing the initial phase of the company's strategy to acquire and develop pre-clinical assets and to then realise value through completing trade-sale transactions. We are pleased to be working with such a well-funded and highly resourced partner to take the Oncogeni portfolio into clinical trials, which if successful, will create long term value for the company," Chief Executive Officer Ajan Reginald says.

----------

SMALL-CAP - LOSERS

----------

Capital Ltd, down 18% at 63.00p, 12-month range 59.40p-105.61p. The mining services provider says it expects to report a decline in profit, as it books non-cash provisions for 2024 relating to historical VAT receivables and various laboratory assets in Mali. In addition, it says its chief executive has tendered his resignation. It now predicts a net profit after tax in the range of USD18 million and USD20 million, a decline of up to 53% from USD38.5 million reported for 2023. For this year, it predicts revenue in the range of USD300 million and USD320 million. "Revenues will be H2 weighted given the ramp up of new projects, predominantly in our mining business, and margins will follow a similar weighting," it adds. Capital has accepted the resignation of CEO Peter Stokes. Stokes will stick around for a "brief transitional period".

----------

SIG PLC, down 2.3% at 12.90p, 12-month range 11.06p-31.00p. RBC cuts its price target for the building products supplier to 16p from 22p. It rates SIG at 'sector perform'.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Roquefort Therapeutics PLC 2.74 GBX 77.06 -
Capital Ltd 62.24 GBX -19.17 -
SIG PLC 12.90 GBX -2.27 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures